Company Overview

Menten AI develops peptide and protein therapeutics using machine learning and quantum computing to accelerate drug discovery and development. The San Francisco-based company applies advanced AI algorithms for cyclic peptide optimization and protein design, with a business model centered on licensing proprietary algorithms and drug candidates to pharmaceutical partners. Founded in 2018 and backed by Y Combinator (W20), Menten AI raised $4.15-4.36M from investors including Khosla Ventures, Uncork Capital, Feld Ventures, Mana Ventures, Quain Investments, Society Health, and Volpini Ventures, and completed a research collaboration with Bristol Myers Squibb in May 2024.

Loading News...
Loading Timeline...
Loading Culture...
Loading Leadership...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Emerging Innovator

Menten AI is an emerging player bringing innovative solutions to the Healthcare market.

Frequently Asked Questions

AI Visibility Rankings

How Menten AI performs in AI search results

AI Rank
?
Track your position
Platforms
5
ChatGPT, Gemini, Claude...
Visibility
?
Your mention rate
Premium Feature

Unlock AI Visibility Tracking for Menten AI

See exactly how Menten AI ranks across ChatGPT, Gemini, Perplexity, Claude, and Grok. Get actionable insights to improve your AI search performance.

Real-time Rankings
Track your position daily
Competitive Intel
See how you compare
Platform Breakdown
Per-AI performance
Actionable Insights
Optimize your visibility
Start Tracking for Free

Join 1,000+ brands · Free 7-day trial · No credit card required

Want to improve your AI visibility? Track performance across all major AI platforms.
Compare with Other Brands

Compare with Other Brands

See how Menten AI stacks up against competitors with our detailed comparison tool.

Start Comparison